AzTrials
AzTrials

Healthy SubjectsFruEx2NCT01866215

Effects of Exercise on Fructose Metabolism

A study testing exercise, fructose and glucose in people with Healthy Subjects, run by University of Lausanne at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate 1. Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy Subjects
What is being tested?
exercise, fructose and glucose
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteSwitzerland
Study dates
May 2013to Jan 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • males
  • 18-40 years old
  • 19 kg/m2>BMI>25kg/m2
  • moderate to high usual physical activity
  • non-smokers

Who cannot join

  • family history of diabetes mellitus
  • ECG anomaly
  • any medication
  • participation to blood spending or other clinical study in the 3 months before the beginning of this study
  • consumption of drugs
  • consumption of more than 50g alcool/week
  • family history of food intolerance

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Centre Hospitalier Universitaire Vaudois

    Lausanne, Canton of Vaud, CH-1011

Other trials in Switzerland

About this study

A high fructose diet increases fasting and post-prandial triglyceride (TG) concentrations in sedentary healthy human subjects.These effects may be secondary to fructose-induced hepatic de novo lipogenesis. Recent evidence indicate that exercise can prevent fructose induced dyslipidemia.This study will evaluate

  1. how exercise effects the metabolic fate of oral fructose 1a) when exercise is performed before fructose ingestion 1b) when exercise is performed after fructose ingestion Metabolic effects of exercise will be assessed in healthy male subjects by measuring fructose oxidation (13CO2 production), fructose conversion into glucose (13C glucose concentrations in blood) and hepatic fructose conversion into lipid (13C palmitate-very low density lipoprotein (VLDL) concentrations in blood) after ingestion of 13C-labelled fructose meals
  2. how fructose and protein modulate muscle glycogen and intramyocellular lipid repletion after exercise Healthy male subjects will be fed various fructose, glucose, lipid and whey protein meals after a glycogen/intramyocellular lipid depleting exercise. The effects of meals' composition will be assessed after 24 hours by measuring intramyocellular lipids and glycogen using proton-magnetic resonance spectroscopy (MRS).
Being tested
exercise, fructose, glucose
Keywords
gluconeogenesis, de novo lipogenesis, intramyocellular lipids, muscle glycogen, fructose

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exerciseOther

    cycling at 100W during 60 min

  • fructoseDietary supplement

    isocaloric nutrition with fructose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise

  • glucoseDietary supplement

    isocaloric nutrition with glucose, cream and whey protein during the 24 hour following a glycogen/intramyocellular lipid depleting exercise

Study groups in NCT01866215
Study groupRoleWhat they receive
Study1aExperimentalexercice performed 90 min before 13C fructose meal ingestion
Receives: Other: exercise
study 1bExperimentalexercise performed 90 min after 13C fructose meal ingestion
Receives: Other: exercise
study 1cNo interventionno exercise
study 2aExperimentalmeals containing fructose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise
Receives: Dietary Supplement: fructose
study 2bActive comparatormeals containing glucose, cream and whey proteins over 24 hours after a glycogen/intramyocellular lipid depleting exercise
Receives: Dietary Supplement: glucose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plasma triglyceride

    measurement of total and VLDL-TG concentrations in study 1

    Measured: measurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)

  2. intramyocellular lipids

    Measurement by 1H-MRS in muscle vastus lateralis in study 2

    Measured: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

  3. Fructose conversion into lipids

    Estimated from 13C palmitate-VLDL concentration

    Measured: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

Secondary outcomes (4)
  1. Fructose conversion into glucose

    measurements obtained from plasma 13C glucose concentrations and whole body glucose production measured by 6,6 d2 glucose in study 1)

    Measured: measured between 7:00 am and 4:oo pm (up to 9 hours)

  2. intramyocellular glycogen concentrations

    Measured by 1H-MRS in muscle vastus lateralis in study 2

    Measured: after glycogen/intramyocellular lipid depleting exercise and after 24 hour controlled feeding post exercise

  3. fructose oxidation

    Calculated from breath 13CO2 production

    Measured: measured from 7:00 am to 4:00 pm in study 1 (up to 9 hours)

  4. exogenous lipid oxidation

    Lipids ingested will be labeled with 13C-triolein, and exogenous lipid oxidation will be measured from breath 13CO2 production

    Measured: measured from 7:00 am to 4:00 pm in study 2 (up to 9 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionJan 2014
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01866215
Sponsor's protocol ID
University of Lausanne
Acronym
FruEx2
Status last verified
Jun 2014
First submitted
27 May 2013
Last updated
4 Jun 2014
Results posted
No
Data monitoring committee
No

Publications

  • Rosset R, Lecoultre V, Egli L, Cros J, Dokumaci AS, Zwygart K, Boesch C, Kreis R, Schneiter P, Tappy L. Postexercise repletion of muscle energy stores with fructose or glucose in mixed meals. Am J Clin Nutr. 2017 Mar;105(3):609-617. doi: 10.3945/ajcn.116.138214. Epub 2017 Jan 18.

    PubMed 28100512
  • Egli L, Lecoultre V, Cros J, Rosset R, Marques AS, Schneiter P, Hodson L, Gabert L, Laville M, Tappy L. Exercise performed immediately after fructose ingestion enhances fructose oxidation and suppresses fructose storage. Am J Clin Nutr. 2016 Feb;103(2):348-55. doi: 10.3945/ajcn.115.116988. Epub 2015 Dec 23.

    PubMed 26702120

Questions about this trial

What is this clinical trial studying?

A study testing exercise, fructose and glucose in people with Healthy Subjects, run by University of Lausanne at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jun 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plasma triglyceride (time frame: measurements in fasting conditions and every hour from 7:00 am to 4:00 pm (up to 9 hours)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01866215, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in